2020-07-13 16:42:00
Coronavirus

BENGALURU :
Two experimental coronavirus vaccines by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received the U.S. Food and Drug Administration’s ‘fast track’ designation, the companies said on Monday, according to Reuters.

The vaccines, BNT162b1 and BNT162b2, are the two most advanced of the four vaccines being developed by the companies.

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Subscribe to newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

Read more

Leave a Comment

Your email address will not be published. Required fields are marked *

ABOUT

Get post 24 hours a day, 7 days a week.

CONTACT US

Bangalore, India
[email protected]

Scroll to Top